Review article · 9 Jun 2025
Conference abstractPublished 17 Sep 2018
Targeting resistin signaling pathway as a strategy for enhancing the effect of chemotherapy drugs in reducing breast cancer cells aggressiveness
Gerald J Friedman Diabetes Institute at Lenox Hill Hospital, USA; The Feinstein Institute for Medical Research, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Obesity has been linked to increased cancer incidence and poor clinical outcome. Levels of resistin, a proinflammatory cytokine produced by the white adipose tissue adipocytes and macrophages, are found to be elevated in obese individuals. Our results demonstrated that in MCF-7 breast cancer cells, resistin induces the formation of filopodia and lamellipodia, reorganization of the cellular stress fibers and separation of single cells from the cellular clusters. We also observed increased breast cancer cell migration after resistin treatment of MCF-7 and MDA-MB-231 cells subjected to scratch migration wound healing assay. Further experiments revealed that resistin upregulates mRNA and protein expression of key transcription factors involved in the epithelial to mesenchymal transition (SNAIL, SLUG, ZEB1 and TWIST) and the mesenchymal markers fibronectin and vimentin. In the same time, the expression of the epithelial markers E-cadherin and claudin-1 was downregulated. Recent studies have shown that resistin also interferes with chemotherapy affecting the efficacy of doxorubicin, significantly attenuating doxorubicin-induced apoptosis in a dose- and time-dependent manner. Here, we propose a hypothesis that creating a monoclonal antibody drug that either blocks resistin signaling pathway or marks resistin for further destruction by lymphocytes, can be a potential strategy for enhancing the effect of chemotherapy drugs on apoptosis and/or attenuating the aggressiveness of cancer cells.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dimiter Avtanski”
- BylineArticles whose byline prints “Beatriz Caraballo”
- BylineArticles whose byline prints “Leonid Poretsky”
